Preservative free artificial tear gel.    (DrugBank: -)

1 disease
IDDisease name (Link within this page)Number of trials
157Sturge-Weber syndrome1

157. Sturge-Weber syndrome    [ 8 clinical trials,   11 drugs,   (DrugBank: 4 drugs),   5 drug target genes,   62 drug target pathways]
Searched query = "Sturge-Weber syndrome", "Síndrome de Sturge-Weber"
The queries were searched in Public_title, Scientific_title, and Condition. Export date: 03/15/2021. Trials are sorted by Date_enrollment from most recent to oldest in the table.
1 / 8 trial found
No.TrialIDDate_
enrollment
Date_
registration
Public_titleScientific_titleConditionInterventionPrimary_
sponsor
Secondary_
sponsor
Recruitment_
Status
Inclusion_
agemin
Inclusion_
agemax
Inclusion_
gender
Target_
size
PhaseCountries
1NCT01533376
(ClinicalTrials.gov)
February 201211/2/2012Treatment of Port-wine Mark in Sturge-Weber Syndrome Using Topical TimololTreatment of Port-wine Mark in Sturge-Weber Syndrome Using Topical TimololSturge Weber Syndrome;Port-wine MarkDrug: Timolol;Drug: Preservative free artificial tear gel.Wills EyeUniversity of Medicine and Dentistry of New JerseyTerminated2 Years10 YearsAll3Phase 1United States